Aktywność arylosulfatazy A w moczu dawców narządów ze śmiercią mózgu jako czynnik prognostyczny wczesnej i późnej funkcji przeszczepu

ARTYKUŁ PRZEGLĄDOWY

Aktywność arylosulfatazy A w moczu dawców narządów ze śmiercią mózgu jako czynnik prognostyczny wczesnej i późnej funkcji przeszczepu

Ewa Kwiatkowska 1 , Leszek Domanski 1 , Joanna Bober 2 , Krzysztof Safranow 3 , Andrzej Pawlik 4 , Kazimierz Ciechanowski 1

1. Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University in Szczecin, Poland
2. Department of Medical Chemistry, Pomeranian Medical University, Szczecin, Poland
3. Department of Biochemistry, Pomeranian Medical University, Szczecin, Poland
4. Department of Physiology, Pomeranian Medical University, Szczecin, Poland

Opublikowany: 2017-01-04
DOI: 10.5604/01.3001.0010.3784
GICID: 01.3001.0010.3784
Dostępne wersje językowe: pl en
Wydanie: Postepy Hig Med Dosw 2017; 71 : 1-4

 

Abstrakt

Przypisy

  • 1. Bezouska K., Yuen C.T., O’Brien J., Childs R.A., Chai W., Lawson A.M., Drbal K., Fiserová A., Pospísil M., Feizi T.: Oligosaccharide ligands for NKR‑P1 protein activate NK cells and cytotoxicity. Nature, 1994; 372: 150‑157
    Google Scholar
  • 2. Bhattacharyya S., Tobacman J.K.: Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia. PLoS One, 2012; 7: e33250
    Google Scholar
  • 3. Damman J., Seelen M.A., Moers C., Daha M.R., Rahmel A., Leuvenink H.G., Paul A., Pirenne J., Ploeg R.J.: Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient. Transplantation, 2011; 92: 163‑169
    Google Scholar
  • 4. de Vries D.K., Lindeman J.H., Ringers J., Reinders M.E., Rabelink T.J., Schaapherder A.F.: Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantation. Am. J. Transplant., 2011; 11: 1064‑1070
    Google Scholar
  • 5. Halsall D.J., Halligan E.P., Elsey T.S., Cox T.M.: Metachromatic leucodystrophy: a newly identified mutation in arylsulphatase A, D281Y, found as a compound heterozygote with I179L in an adult onset case. Hum. Mutat., 1999; 14: 447
    Google Scholar
  • 6. Ishizuka I.: Chemistry and functional distribution of sulfoglycolipids. Prog. Lipid Res., 1997; 36: 245‑319
    Google Scholar
  • 7. Kabayama K., Ito N., Honke K., Igarashi Y., Inokuchi J.: Suppression of integrin expression and tumorigenicity by sulfation of lactosylceramide in 3LL Lewis lung carcinoma cells. J. Biol. Chem., 2001; 276: 26777‑26783
    Google Scholar
  • 8. Kobayashi T., Honke K., Kuramitsu Y., Hosokawa M., Miyazaki T., Murata J., Saiki I., Ishizuka I., Makita A.: Cell‑surface sulfoglycolipids are involved in the attachment of renal‑cancer cells to laminin. Int. J. Cancer, 1994; 56: 281‑285
    Google Scholar
  • 9. Kobayashi T., Honke K., Kamio K., Sakakibara N., Gasa S., Miyao N., Tsukamoto T., Ishizuka I., Miyazaki T., Makita A.: Sulfolipids and glycolipid sulfotransferase activities in human renal cell carcinoma cells. Br. J. Cancer, 1993; 67: 76‑80
    Google Scholar
  • 10. Koo D.D., Welsh K.I., McLaren A.J., Roake J.A., Morris P.J., Fuggle S.V.: Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. Kidney Int., 1999; 56: 1551‑1559
    Google Scholar
  • 11. Li G., Hu R., Kamijo Y., Nakajima T., Aoyama T., Ehara T., Shigematsu H., Kannagi R., Kyogashima M., Hara A.: Kidney dysfunction induced by protein overload nephropathy reduces serum sulfatide levels in mice. Nephrology, 2009; 14: 658‑662
    Google Scholar
  • 12. Matas A.J., Humar A., Gillingham K.J., Payne W.D, Gruessner R.W., Kandaswamy R., Dunn D.L., Najarian J.S., Sutherland D.E.: Five preventable causes of kidney graft loss in the 1990s: A single‑center analysis. Kidney Int., 2002; 62: 704‑714
    Google Scholar
  • 13. Németh M., László A., Kovács A., Falkay G.: Lysosomal enzyme activities in frozen, non‑cultured chorionic villi for prenatal diagnosis of enzymopathies. Acta Med. Hung., 1992‑1993; 49: 143‑148
    Google Scholar
  • 14. Parenti G., Meroni G., Ballabio A.: The sulfatase gene family. Curr. Opin. Genet. Dev., 1997; 7: 386‑391
    Google Scholar
  • 15. Schuurs T.A., Gerbens F., van der Hoeven J.A., Ottens P.J., Kooi K.A., Leuvenink H.G., Hofstra R.M., Ploeq R.J.: Distinct transcriptional changes in donor kidneys upon brain death induction in rat: insight in the processes of brain death. Am. J. Transplant., 2004; 4: 1972‑1981
    Google Scholar
  • 16. Tadano‑Aritomi K., Hikita T., Fujimoto H., Suzuki K., Motegi K., Ishizuka I.: Kidney lipids in galactosylceramide synthase‑deficient mice. Absence of galactosylsulfatide and compensatory increase in more polar sulfoglycolipids. J. Lipid Res., 2000; 41: 1237‑1243
    Google Scholar
  • 17. Terasaki P.I., Cecka J.M., Gjertson D.W., Takemoto S.: High survival rates of kidney transplants from spousal and living unrelated donors. N. Engl. J. Med., 1995; 333: 333‑336
    Google Scholar
  • 18. Von Figura K., Schmidt B., Selmer T., Dierks T.: A novel protein modification generating an aldehyde group in sulfatases: its role in catalysis and disease. Bioessays, 1998; 20: 505‑510
    Google Scholar
  • 19. Weiss S., Kotsch K., Francuski M., Reutzel‑Selke A., Mantouvalou L., Klemz R., Kuecuek O., Jonas S., Wesslau C., Ulrich F., Pascher A., Volk H.D., Tullius S.G., Neuhaus P., Pratschke J.: Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am. J. Transplant., 2007; 7: 1584‑1593
    Google Scholar
  • 20. Werner M.J., Maruhn D., Atoba M.: Use of gel filtration in the assay of urinary enzymes. J. Chromatogr., 1969; 40: 254‑263
    Google Scholar

Pełna treść artykułu

Przejdź do treści